Alzheimers & Dementia-Translational Research & Clinical Interventions

Scope & Guideline

Transforming Research into Real-World Solutions

Introduction

Delve into the academic richness of Alzheimers & Dementia-Translational Research & Clinical Interventions with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN-
PublisherWILEY
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationALZH DEMENT-TRCI / Alzheimers Dement.-Transl. Res. Clin. Interv.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

The journal 'Alzheimers & Dementia: Translational Research & Clinical Interventions' focuses on bridging the gap between basic research and clinical applications in the field of Alzheimer's disease and related dementias. It aims to provide a platform for innovative research that offers insights into the pathophysiology, diagnosis, treatment, and care of Alzheimer's disease.
  1. Clinical Applications of Biomarkers:
    The journal emphasizes research on biomarkers that can aid in the diagnosis and monitoring of Alzheimer's disease. This includes studies on cerebrospinal fluid (CSF) biomarkers, plasma markers, and neuroimaging techniques to track disease progression.
  2. Pharmacological Interventions:
    A significant focus is on the development and evaluation of pharmacological treatments, including anti-amyloid therapies and other disease-modifying agents. This encompasses clinical trials and their design, efficacy, and safety.
  3. Social and Behavioral Aspects of Dementia Care:
    Research related to the psychosocial aspects of dementia care, including caregiver support, patient-centered care strategies, and the impact of social connections on health outcomes is a core area of interest.
  4. Health Disparities and Inclusion:
    The journal addresses issues of diversity and inclusion in Alzheimer's research, emphasizing the importance of studying underrepresented populations and understanding how social determinants affect health outcomes.
  5. Innovative Methodologies:
    The journal promotes the use of novel methods in Alzheimer's research, including machine learning, digital health technologies, and community-based participatory research approaches.
The journal has seen a rise in themes that reflect contemporary issues and advancements in Alzheimer's research. These emerging areas indicate a shift towards more integrative and inclusive approaches to understanding and treating the disease.
  1. Diversity and Inclusion in Research:
    There is an increasing emphasis on the importance of diversity in research populations, addressing health disparities, and ensuring that findings are applicable across different racial, ethnic, and socio-economic groups.
  2. Digital Health Interventions:
    The trend towards digital health solutions, including telehealth, mobile health applications, and online cognitive training programs, is gaining traction as a means to enhance patient engagement and accessibility.
  3. Personalized Medicine Approaches:
    Research that aims to tailor interventions based on individual genetic, biomarker, and lifestyle profiles is on the rise, highlighting a shift towards personalized treatment strategies for Alzheimer's disease.
  4. Holistic and Multidimensional Care Models:
    There is a growing focus on holistic care models that integrate physical, mental, and social health, recognizing the multifaceted nature of dementia and its impact on overall well-being.
  5. Community-Based Participatory Research:
    Increasingly, research methodologies that involve community engagement and collaboration with stakeholders are emerging, reflecting a commitment to addressing real-world challenges faced by individuals with dementia and their caregivers.

Declining or Waning

As the landscape of Alzheimer's research evolves, certain themes within the journal have shown a decline in prominence. This may reflect shifting priorities or advancements in other areas of research.
  1. Traditional Neuropsychological Assessments:
    There appears to be a waning focus on traditional neuropsychological assessments as primary outcomes in Alzheimer's studies, with a shift towards more dynamic and holistic measures of cognition and functionality.
  2. Single-Domain Interventions:
    Research concentrating solely on single-domain interventions, such as cognitive training or pharmacological treatments without integrated approaches, is decreasing as multidisciplinary strategies become more favored.
  3. Cultural Competency Training:
    While once a focal point, specific studies on cultural competency training for dementia care providers are becoming less frequent, possibly as the field moves towards broader systemic changes rather than isolated training programs.
  4. Basic Mechanistic Studies:
    Research centered exclusively on basic mechanistic studies without translational implications is declining, as there is a stronger emphasis on studies that can directly inform clinical practice and patient outcomes.
  5. Epidemiological Studies on Non-Dementia Populations:
    There is a noticeable reduction in studies focusing on the epidemiology of cognitive decline in non-dementia populations, as the journal pivots towards more targeted research on individuals diagnosed with Alzheimer's disease.

Similar Journals

Current Geriatrics Reports

Navigating the complexities of aging with cutting-edge research.
Publisher: SPRINGERISSN: Frequency: 4 issues/year

Current Geriatrics Reports is a pivotal journal published by SPRINGER, dedicated to disseminating cutting-edge research and insights in the dynamic field of geriatrics and gerontology. Launched in 2014 and ongoing until 2024, this journal plays a critical role in addressing the complex needs and challenges faced by the aging population. Although it currently holds a Q4 quartile ranking in its category and occupies the 84th position out of 116 in the Scopus metrics for Medicine, Geriatrics, and Gerontology, it serves as a vital platform for emerging research that shapes clinical practices and policy-making. Researchers, professionals, and students alike will find Current Geriatrics Reports to be an invaluable resource for staying updated on advancements, best practices, and innovations in geriatric care. While the journal is not open access, it continues to impact the field significantly and enrich contemporary discussions surrounding aging.

Dementia and Geriatric Cognitive Disorders Extra

Exploring innovative research in geriatric neuroscience.
Publisher: KARGERISSN: Frequency: 3 issues/year

Dementia and Geriatric Cognitive Disorders Extra, published by KARGER in Switzerland, is an esteemed open-access journal dedicated to advancing research in the fields of cognitive neuroscience, geriatrics, and psychiatry. With a commitment to disseminating high-quality research since its inception in 2011, the journal plays a crucial role in highlighting innovative studies that address cognitive disorders associated with aging. As an open-access platform, it ensures that findings are accessible to a global audience, fostering collaboration and knowledge-sharing among researchers, professionals, and students alike. The journal has been recognized for its impact in Cognitive Neuroscience and Psychiatry and Mental Health, achieving a Q3 category ranking, indicating its reputable standing within these fields. By delivering cutting-edge insights and promoting interdisciplinary approaches, Dementia and Geriatric Cognitive Disorders Extra is instrumental in enhancing understanding and treatment of cognitive decline, making it a vital resource for anyone engaged in the study of aging and cognitive health.

JAMA Neurology

Advancing Neurological Insights for Tomorrow's Treatments
Publisher: AMER MEDICAL ASSOCISSN: 2168-6149Frequency: 12 issues/year

JAMA Neurology is a leading peer-reviewed journal published by the American Medical Association, focused on advancing the understanding and treatment of neurological disorders. With an impressive impact factor and ranked in the 99th percentile among clinical neurology journals, this publication is recognized as Q1 in its category for 2023, highlighting its significance in the field. Since its inception, the journal has provided a platform for high-quality research, clinical trials, and reviews that inform both clinicians and researchers. Operating from its headquarters in Chicago, Illinois, JAMA Neurology offers rich insights into the latest advancements in neurology, featuring articles that span a wide range of topics including neurodegenerative diseases, stroke, epilepsy, and neurocritical care. Researchers and professionals are encouraged to access the journal’s content freely, as it employs open access options to promote the dissemination of critical knowledge. As a critical resource in the field of neurology, JAMA Neurology is essential for anyone involved in this dynamic and rapidly evolving specialty.

Canadian Geriatrics Journal

Shaping the future of geriatric care through open access.
Publisher: MULTIMED INCISSN: Frequency: 4 issues/year

Canadian Geriatrics Journal, published by MULTIMED INC, is a prominent platform dedicated to advancing the field of geriatrics and gerontology. With its esteemed status as a Q2 journal in both Geriatrics and Gerontology categories for 2023, it ranks favorably within the academic community, holding a 73rd percentile in Nursing Gerontology and a 59th percentile in Medicine Geriatrics and Gerontology according to Scopus metrics. Since its inception in 2011, the journal has aimed to foster innovation and disseminate pivotal research that addresses the complexities of aging populations. Researchers, healthcare professionals, and students interested in the intricacies of geriatric care will find a wealth of open-access resources that contribute significantly to enhancing practice and care methodologies in Canada and beyond. With its address located at 66 Martin St, Toronto, ON L9T 2R2, Canada, the journal stands as a vital resource for stakeholders in the geriatric field.

American Journal of Alzheimers Disease and Other Dementias

Innovating solutions for neurodegenerative challenges.
Publisher: SAGE PUBLICATIONS INCISSN: 1533-3175Frequency: 81 issues/year

The American Journal of Alzheimer's Disease and Other Dementias, published by SAGE Publications Inc, is a pivotal resource for researchers, clinicians, and students engaged in the study of neurodegenerative diseases, particularly Alzheimer’s disease and various forms of dementia. With an impact factor reflecting its significance in the field, the journal boasts an open-access format since 2020, ensuring that groundbreaking research is accessible to a global audience. The journal holds prestigious Q2 rankings across several categories, including Clinical Psychology, Geriatrics and Gerontology, Neuroscience, and Psychiatry and Mental Health. Covering a wide spectrum from 1986 to 2024, it provides essential insights into innovative treatments, care strategies, and the latest findings in dementia research, solidifying its importance in fostering knowledge and advancing the field. With a commitment to high-quality scholarship, this journal is an indispensable tool for advancing understanding in the dynamic landscape of dementia studies.

Alzheimers Research & Therapy

Empowering the fight against Alzheimer's through open access.
Publisher: BMCISSN: Frequency: 1 issue/year

Alzheimer's Research & Therapy is a leading peer-reviewed journal published by BMC, dedicated to advancing our understanding of Alzheimer's disease and other neurodegenerative disorders. As an Open Access journal since 2009, it ensures that vital research findings are freely accessible to the global community, facilitating collaboration and innovation in the field. The journal's commitment to quality is evident in its impressive impact factor and its prestigious ranking in the Q1 quartile across multiple categories including Cognitive Neuroscience and Neurology. With a Scopus rank placing it in the top tier of both Neuroscience and Neurology disciplines, Alzheimer's Research & Therapy serves as a crucial platform for researchers, clinicians, and students who seek to contribute to the fight against Alzheimer's and related disorders. The journal covers a wide range of topics and actively encourages submissions that explore therapeutic strategies and innovative research methodologies, enriching the scientific dialogue in this vital area of health.

JOURNAL OF ALZHEIMERS DISEASE

Uniting disciplines to combat Alzheimer's disease.
Publisher: IOS PRESSISSN: 1387-2877Frequency: 24 issues/year

Journal of Alzheimer's Disease, published by IOS Press, stands as a pivotal resource in the fight against Alzheimer's and related neurodegenerative disorders. With an ISSN of 1387-2877 and an E-ISSN of 1875-8908, this esteemed journal has evolved since its inception in 1998, providing a vital platform for academic research and clinical practice in the realms of Clinical Psychology, Geriatrics and Gerontology, Neuroscience, and Psychiatry and Mental Health. Ranked in the Q1 category across several disciplines, including Clinical Psychology and Geriatrics, this journal not only highlights significant advancements in understanding Alzheimer's disease but also fosters interdisciplinary dialogue among researchers, healthcare professionals, and policymakers. Boasting robust Scopus rankings—such as 49th in Clinical Psychology and 29th in Geriatrics—this journal is committed to disseminating high-quality research that informs both therapeutic strategies and public health initiatives. The Journal of Alzheimer's Disease is an essential resource for anyone dedicated to exploring the complexities of cognitive decline and enhancing care for affected individuals.

JAMA Psychiatry

Exploring the Frontiers of Psychiatry and Clinical Practice
Publisher: AMER MEDICAL ASSOCISSN: 2168-622XFrequency: 12 issues/year

JAMA Psychiatry, published by the American Medical Association, stands as a leading peer-reviewed journal in the fields of psychiatry and mental health, featuring an impressive impact factor that reflects its significance in advancing research and clinical practice. With an ISSN of 2168-622X and an E-ISSN of 2168-6238, this journal operates on a comprehensive access model that allows for the dissemination of vital research findings to a global audience. Since its inception in 2013, JAMA Psychiatry has consistently ranked in the top quartile (Q1) in both the Medicine (miscellaneous) and Psychiatry and Mental Health categories, with a remarkable Scopus rank of #4 out of 567, placing it in the 99th percentile. Addressed from its headquarters in Chicago, Illinois, the journal's objectives encompass the publication of original clinical research, innovative treatment strategies, and insightful reviews that enrich the understanding of psychiatric disorders. By bridging the gap between research and real-world application, JAMA Psychiatry remains an essential resource for researchers, clinicians, and students dedicated to improving mental health outcomes.

Quality in Ageing and Older Adults

Illuminating Pathways to Enhanced Aging Experiences
Publisher: EMERALD GROUP PUBLISHING LTDISSN: 1471-7794Frequency: 4 issues/year

Quality in Ageing and Older Adults is an esteemed journal published by Emerald Group Publishing Ltd, dedicated to elucidating the complexities and challenges of aging and the quality of life for older adults. With a focus on critical areas within Care Planning, Community and Home Care, and Gerontology, this journal serves as a vital resource for researchers, healthcare professionals, and students alike. Recognized for its scholarly contributions, it holds a Q2 ranking for Care Planning and Community and Home Care and maintains an impactful presence in Gerontology, further demonstrated by its Scopus rankings. Although the journal does not offer open access, its commitment to advancing knowledge in the field is underscored by its ongoing publication since 2000 and its broad scholarly reach until 2024. By fostering innovative research and practical insights, Quality in Ageing and Older Adults continues to play a crucial role in informing policy, enhancing care practices, and improving outcomes for older individuals.

Journal of Gerontological Nursing

Innovating Nursing for a Greying World
Publisher: SLACK INCISSN: 0098-9134Frequency: 12 issues/year

The Journal of Gerontological Nursing, published by SLACK INC, is a leading peer-reviewed journal dedicated to advancing the field of gerontological nursing through innovative research, clinical practice, and educational advancements. Since its inception in 1975, this journal has become a crucial resource for researchers, healthcare professionals, and students interested in the care and management of older adults. With an impact factor that reflects its significance within the disciplines of gerontology and nursing (Category Quartiles: Q3 in Gerontology and Q3 in Nursing), it serves as a platform for disseminating vital findings, best practices, and evidence-based approaches aimed at improving the quality of life for the aging population. While the journal maintains a print-only format, its content is invaluable for those looking to stay ahead in the rapidly evolving landscape of gerontological care. As it continues to publish until 2024, the Journal of Gerontological Nursing invites contributions that foster dialogue and innovation within this essential area of healthcare.